On October 24, 2022 Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, reportes that the management team will participate in four upcoming investor conferences in October and November 2022 as follows (Press release, Transcenta, OCT 24, 2022, View Source [SID1234622321]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
1) 2022 Listed Companies Roadshow Conference* Season 3 (Pharmaceutical and Biological Industry)
Time: Tuesday, October 25, 2022—Thursday, October 27, 2022
Online one-on-one meeting/group meeting
Organizer: Essence International Financial Holdings Limited &
Sullivan International Limited & Roadshow China;
2) 2022 DJSeedin Innovation Partnering Conference
Time: Thursday,November 03, 2022—Friday, November 04, 2022
Mandarin Oriental Pudong Shanghai
Organizer: PharmaDJ&bioSeedin
3) 2022 IDEAS Summit
Time:Tuesday, November 08, 2022—Friday, November 11, 2022 (9:30am -18:00pm)
Online one-on-one meeting/group meeting
Organizer: Wonderful Sky
4) Goldman Sachs Asia Pacific Healthcare Forum 2022 (Virtual)
Time:Tuesday, November 15, 2022—Friday, November 18, 2022
Online one-on-one meeting/group meeting
Organizer: Goldman Sachs